244 – CRI Report

Next-Generation Breast Cancer Diagnostic and Screening Market – A Global Market and Regional Analysis: Focus on Technology, Cancer Sub-Type, Biomarker, Offering, End User, and Country Analysis – Analysis and Forecast, 2023-2032

admin — Thu, 25 May 2023 01:40:58 +0000

Global Next-Generation Breast Cancer Diagnostic and Screening Market: Industry Overview

The global next-generation breast cancer diagnostic and screening market was valued at $3,137.4 million in 2022 and is anticipated to reach $9,880.1 million by 2032, witnessing a CAGR of 12.57% during the forecast period 2023-2032.

The growth in the global next-generation breast cancer diagnostic and screening market is expected to be driven by the increase in the prevalence of breast cancer cases globally, rising awareness regarding early diagnosis of breast cancer, growing focus on breast cancer biomarkers for effective screening, prognosis, and personalized treatment, and increasing partnerships and collaborations amongst market players.

Market Lifecycle Stage

The next-generation breast cancer diagnostic and screening market is in the developing phase. Technological advancements in the development of next-generation breast cancer diagnostics and the growing scope for molecular breast cancer diagnosis techniques in emerging countries can be some of the major opportunities in the global next-generation breast cancer diagnostic and screening market. Furthermore, some of the key trends going on in the market are the implementation of liquid biopsy for breast cancer diagnosis and the complete automation of next-generation techniques.

Impact of COVID-19

COVID-19 had a significant impact on the global next-generation breast cancer diagnostic and screening market. There was a significant shift observed toward research activities for treating and diagnosing COVID-19, which resulted in a halt in research activities for next-generation breast cancer diagnostic and screening. Moreover, the market players witnessed a loss in 2020 due to COVID-19 restrictions and prevention actions such as a reduction in supply chain and sales.

However, since the situations are now almost back to normal, the next-generation breast cancer diagnostic and screening market is expected to overcome all the Impact of COVID-19 during the forecast period 2023-2032.

Market Segmentation:

Segmentation 1: by Technology
• Real-Time PCR
• Immunohistochemistry (IHC)
• Next-Generation Sequencing (NGS)
• Fluorescence In-Situ Hybridization (FISH)
• Others

Based on technology, the global next-generation breast cancer diagnostic and screening market is expected to be dominated by the immunohistochemistry (IHC) segment.

Segmentation 2: by Biomarker
• BRCA1/2
• ER/PR Receptors
• HER-2
• Others

Based on biomarker, the global next-generation breast cancer diagnostic and screening market is dominated by the BRCA1/2 segment.

Segmentation 3: by Cancer Sub-Type
• Luminal A
• Luminal B
• Triple Negative/Basal Like
• Human Epidermal Growth Factor Receptor 2 (HER-2) Enriched

Based on cancer sub-type, the global next-generation breast cancer diagnostic and screening market is dominated by the luminal A segment.

Segmentation 4: by Offering
• Products
• Services

Based on offering, the global next-generation breast cancer diagnostic and screening market is dominated by the services segment.

Segmentation 5: by End User
• Hospitals and Clinics
• Diagnostic Centers and Reference Labs
• Academic and Research Institutes

Based on end user, the global next-generation breast cancer diagnostic and screening market is dominated by the hospitals and clinics segment.

Segmentation 6: by Region
• North America – U.S., Canada
• Europe – Germany, France, U.K., Italy, Spain, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, Australia, South Korea, Singapore, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

Based on region, the global next-generation breast cancer diagnostic and screening market is dominated by North America.

Recent Developments in the Global Next-Generation Breast Cancer Diagnostic and Screening Market

• In April 2023, Syantra Inc., a Canada-based company, received CE mark approval for its Syantra DX breast cancer test.
• In March 2023, NeoGenomics, Inc. launched its RaDaR assay, which is a liquid biopsy test for minimal residual disease (MRD).
• In February 2023, HALO Diagnostics launched its new HALO pathway for early breast cancer detection.
• In January 2023, Agilent Technologies, Inc. acquired Avida Biomed, a company that develops high-performance NGS target enrichment workflows for cancer research.
• In October 2022, Lucence Diagnostics Pte Ltd entered into a distribution partnership with Omnigen, under which Omnigen would distribute Lucence Diagnostics Pte Ltd’s LiquidHALLMARK assay in Turkey.
• In March 2022, Myriad Genetics, Inc. received the U.S. FDA approval for its BRACanalysis CDx for being used as a companion diagnostic test and for the identification of breast cancer patients who may benefit from Lynparza in early breast cancer stages.
• In February 2022, Laboratory Corporation of America Holdings acquired Personal Genome Diagnostics Inc., a company that deals in cancer genomics and provides an assortment of comprehensive liquid biopsy and tissue-based products.
• In January 2022, Agendia Inc. entered into a partnership with Illumina Inc. to expand genomic testing for breast cancer care.
• In December 2021, Exai Bio, Inc. raised funding of $67.5 million as a part of its Series A funding round. The funding was in order to bring advancement in the next-generation RNA-based liquid biopsy platform of the company, which is indicated for early detection of cancer.
• In June 2021, Veracyte, Inc. acquired HalioDx for an amount of $318 million to expand its portfolio in cancer in-vitro diagnostics.
• In May 2021, Hologic, Inc. acquired Biotheranostics, Inc., a company that provides molecular diagnostic tests for breast and metastatic cancers.
• In November 2020, Agilent Technologies, Inc. received U.S. FDA approval for its PD-L1 IHC 22C3 pharmDx for triple-negative breast cancer.

Demand – Drivers and Limitations

Following are the drivers for the global next-generation breast cancer diagnostic and screening market:

• Increasing Prevalence of Breast Cancer Globally
• Increased Awareness Regarding Early Diagnosis of Breast Cancer
• Growing Focus on Breast Cancer Biomarkers for Effective Screening, Prognosis, and Personalized Treatment
• Increasing Partnerships and Collaborations amongst Market Players

The market is expected to face some limitations as well due to the following restraints:

• High Cost of Tests and Requirement of High Capital Investment for Testing Set-Up
• Occurrence of False Positive and False Negative Results

How can this report add value to an organization?

Product/Innovation Strategy: The technology segment helps the reader understand the different types of technologies being used in next-generation breast cancer diagnosis and screening. Moreover, the study provides the reader with a detailed understanding of the next-generation breast cancer diagnostic and screening market based on biomarkers (BRCA1/2, ER/PR receptors, HER-2, and others), cancer sub-type (luminal A, luminal B, triple negative/basal-like, and HER-2 enriched), and offerings (products and services).

Growth/Marketing Strategy: The global next-generation breast cancer diagnostic and screening market has seen major development by key players operating in the market, such as business expansions, partnerships, collaborations, mergers and acquisitions, product launches, and funding activities. Partnerships, alliances, and business expansions accounted for the maximum number of key developments in the global next-generation breast cancer diagnostic and screening market, followed by regulatory and legal activities and mergers and acquisitions.

Competitive Strategy: Key players in the global next-generation breast cancer diagnostic and screening market analyzed and profiled in the study involve players that offer next-generation breast cancer diagnostic and screening products and services. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, product launches and approvals, and funding scenarios will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, and market penetration.

Key Companies Profiled

• Abbott Laboratories
• Agendia Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• BGI Genomics Co., Ltd.
• CENTOGENE N.V.
• Danaher Corporation
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Laboratory Corporation of America Holdings
• Thermo Fisher Scientific Inc.
• Lucence Diagnostics Pte Ltd
• Myriad Genetics, Inc.
• Natera, Inc.

The post Next-Generation Breast Cancer Diagnostic and Screening Market – A Global Market and Regional Analysis: Focus on Technology, Cancer Sub-Type, Biomarker, Offering, End User, and Country Analysis – Analysis and Forecast, 2023-2032 first appeared on CRI Report.

Smart Crop Monitoring Market – A Global and Regional Analysis: Focus on Product and Application, Supply Chain Analysis, and Country Analysis – Analysis and Forecast, 2022-2027

admin — Sat, 30 Jul 2022 05:33:47 +0000

Global Smart Crop Monitoring Market Industry Overview

The global smart crop monitoring market was valued at $1,927.83 million in 2021, which is expected to grow with a CAGR of 12.75% and reach $3,955.39 million by 2027. The growth in the global smart crop monitoring market is expected to be driven by increasing demand for food and the growing need for precision, digital, and smart agriculture practices.

Market Lifecycle Stage

The smart crop monitoring market is still in an evolving phase. Increased research and development activities are underway to develop smart crop monitoring technologies and products, which are expected to increase due to the increased demand for food and the need for automation in the agriculture sector.

Increasing investment in smart agriculture is one of the major opportunities in the global smart crop monitoring market. Moreover, smart crop monitoring technologies also help in reducing crop losses due to crop diseases and harsh climatic conditions, which aid the farmers in increasing crop quality and quantity.

Impact

• With an increased worldwide focus on achieving the global food demand, the shift to digital, smart, and data-driven products in the agriculture sectors brings significant sales and financing opportunities. The shift is more prominent in automation and robotics segments in regions such as North America and Europe.
• Furthermore, smart crop monitoring has a moderate to high impact on crop protection systems to reduce crop losses due to crop diseases and pest infestations.

Impact of COVID-19

In the wake of the pandemic, labor shortages have caused disruptions in the agricultural processes, thereby leading every country to re-emphasize food security and increase domestic food production. With an aim to solve labor shortages, the increased application of automated technologies such as sensors, data analytics, variable-rate technology, and others have been introduced in the production system. Each country continued to promote policies on increasing the adoption of smart crop monitoring techniques, which have proved to be the appropriate solution.

Market Segmentation:

Segmentation 1: by Application
• Soil Monitoring
• Weather Forecasting
• Yield Monitoring
• Crop Protection
• Others

The global smart crop monitoring market in the application segment is expected to be dominated by crop protection technologies. This is due to smart crop monitoring being a highly beneficial methodology to decrease crop losses due to crop diseases, pest infestations, and harsh climatic conditions.

Segmentation 2: by Type
• Hardware
• Software
• Services

The global smart crop monitoring market is slightly more dominated by the services segment. This is due to the wide variety of services in the form of advisories and consultations, and rental equipment results in the higher adoption and usage by the end users globally.

Segmentation 3: by Technology
• Sensing and Imagery
• Automation and Robotics
• Variable-Rate Technology (VRT)
• Guidance Technology

The automation and robotics segment dominates the global smart crop monitoring market due to the higher adoption of products such as robots, drones, and unmanned aerial vehicles (UAV).

Segmentation 4: by Region
• North America – U.S., Canada, and Mexico
• Europe – Italy, Germany, Spain, France, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific – Japan, India, Australia, and Rest-of-Asia-Pacific
• Middle East and Africa – Saudi Arabia, South Africa
• South America – Brazil, Argentina, Rest-of-South America

North America generated the highest revenue of $701.88 million in 2021, which is attributed to the R&D advancements and supporting government regulations in the region. Europe is an attractive region for the smart crop monitoring market because of the availability of the different market fragments.

Recent Developments in Global Smart Crop Monitoring Market

• In February 2022, Airbus S.A.S and Intelinair partnered to provide Airbus S.A.S’ accurate and satellite-based imagery data to Intelinair’s platform, AGMRI, which is an AI-based crop analytics platform. This would aid in providing farmers with accurate images and data of their fields throughout the crop production cycle.

• In January 2022, iTree Consulting & Services and AGRIVI partnered to bring digital agriculture solutions to farmers and agri-food value chain stakeholders in Mexico.

• In May 2021, AGCO Corporation collaborated with Robert Bosch GmbH, BASF Digital Farming GmbH, and Raven Industries Inc. to innovate and develop precision spraying and variable-rate technologies in the agricultural fields. The collaboration is aimed to make crop protection products more efficient by reducing input costs.

• In March 2021, MAM and Kubota Corporation partnered, aiming to provide agricultural equipment, services, and solutions to Japan.

• In March 2021, CNH Industrial N.V. partnered with ML6 to help transfer an algorithm to a multi-faceted camera. ML6 helped economize and optimize the algorithm and help get it implanted by working with the camera provider, CNH Industrial N.V.

Demand – Drivers and Limitations

Following are the demand drivers for the smart crop monitoring market:

• Need to Reduce Crop Losses
• Higher Yields as Compared to Conventional farming
• Government Support and Initiatives for Smart Crop Monitoring Equipment

The market is expected to face some limitations too due to the following challenges:

• Cyber and Online Data Security
• Lack of Connectivity and Technical Awareness
• High Set-Up Costs

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The product segment helps the reader understand the different types of smart crop monitoring technologies available for deployment in the agriculture sector and their potential globally. Moreover, the study provides the reader with a detailed understanding of different smart crop monitoring products by application (soil monitoring, weather forecasting, yield monitoring, crop protection, and others), by types (hardware, software, and services), and by technology (sensing and imagery, automation and robotics, variable-rate technology, and guidance technology). Crops produced by the utilization of smart crop monitoring technologies generate higher revenues when compared to conventional equipment.

Growth/Marketing Strategy: The global smart crop monitoring market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been product partnerships, joint ventures, and product launches to strengthen their position in the smart crop monitoring market. For instance, in December 2021, Ceres Imaging announced to offer new soil moisture probes as part of its precision irrigation subscription service to farmers in California.

Competitive Strategy: Key players in the global smart crop protection market analyzed and profiled in the study involve smart crop monitoring manufacturers that provide different products. Moreover, a detailed competitive benchmarking of the players operating in the global smart crop monitoring market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

The top segment players leading the market include variable-rate technology (VRT) and automation and robotics, which capture around 52% of the presence in the market. Players in other technologies, such as sensing and imagery and guidance technology, account for approximately 48% of the presence in the market, as of 2021.

Some of the prominent names established in this market are:

Company Type 1: Sensing and Imagery
• Ceres Imaging
• CNH Industrial N.V.
• CropIn Technology Solutions Private Limited
• Deere & Company
• PrecisionHawk, Inc.
• Prospera Technologies
• Climate LLC

Company Type 2: Automation and Robotics
• Kubota Corporation
• Raven Industries Inc.
• Robert Bosch GmbH
• Small Robot Company
• Trimble Inc.

Company Type 3: Guidance Technology
• AGRIVI
• Airbus
• Alibaba Group Holding Limited
• IBM Corporation
• Microsoft Corporation

Company Type 4: Variable-Rate Technology (VRT)
• AGCO Corporation
• CLAAS KGaA mbH
• Granular, Inc.

The post Smart Crop Monitoring Market – A Global and Regional Analysis: Focus on Product and Application, Supply Chain Analysis, and Country Analysis – Analysis and Forecast, 2022-2027 first appeared on CRI Report.

Global Minimally Invasive Gastrointestinal Surgical Systems Market: 12 Countries Analysis – Analysis and Forecast, 2021-2031

admin — Wed, 30 Jun 2021 08:52:14 +0000

Market Report Coverage – Minimally Invasive Gastrointestinal Surgical Systems

Market Segmentation

• Product Type – Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS)[Endoscopes and Endoscopy Systems, Videoscopes, Endoscopic Ultrasound, Therapeutic Energy Devices], Surgical Robotics (Robotic Systems, Robotic Surgery Instruments and Accessories, Services)
• Surgery – Adrenalectomy, Appendectomy, Bariatric Surgery, Cholecystectomy, Colon and Rectal Surgery, Foregut Surgery, Hernia Repair
• End User – Conventional Technologies (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), Surgical Robotics (Hospitals, Ambulatory Surgical Centers, Specialty Clinics)

Regional Segmentation

• North America: U.S. and Canada
• Europe: Germany, U.K, Italy, Spain, France, and Rest-of-Europe
• Asia-Pacific: Japan, China, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific
• Rest-of-the-World

Growth Drivers

• Advantages of Minimally Invasive Surgical Procedures Over Conventional Open Surgical Procedures
• Availability of Technological Advanced Products in the Field of GI Surgical Procedures
• Increasing Healthcare Spending
• Growth in Robotics GI Surgical Procedures

Market Challenges

• High Cost of Minimally Invasive GI Surgical Procedures
• Shortage of Skilled Professionals
• Restrictive Reimbursement Framework

Market Opportunities

• Development of Long-Distance Teleoperated Surgical Robotic Systems
• Mergers and Acquisitions to Diversify Endoscopic Portfolio
• Investment for Regional Expansionts

Key Companies Profiled

Ambu A/S, B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cook Medical Inc., Intuitive Surgical, Inc., Olympus Corporation, Medtronic plc, Karl Storz SE & Co. KG, Stryker Corporation, Schölly Fiberoptic GmbH, Xenocor Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Richard Wolf GmbH, and TransEnterix, Inc.

Key Questions Answered in this Report:

• What is the current market size and future potential of these products?
• What is the current market share and growth share of the different products in the market?
• What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive gastrointestinal surgical systems?
• What are the major market drivers, restraints, and opportunities in the global minimally invasive gastrointestinal surgical systems market?
• What is the impact of the COVID-19 pandemic on the market?
• Which technology is being researched and worked upon to improve the gastrointestinal surgical systems?
• Who are the leading players dominating the global minimally invasive gastrointestinal surgical systems market?
• What are the key development and strategies incorporated by the players of global minimally invasive gastrointestinal surgical systems market, to sustain the competition and retain their supremacy?
• Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global minimally invasive gastrointestinal surgical systems market?
• How advanced technologies such as surgical robotics is gaining traction in terms of market share in in gastrointestinal space?

Overview on the Global Minimally Invasive Gastrointestinal Surgical Systems Market

The global minimally invasive gastrointestinal surgical systems market is currently witnessing a significant change in the market landscape. There is rising investment in the development of healthcare infrastructure, increasing evidence for efficient and promising results in surgery assistance. Thus, this is leading to potential growth opportunities for the minimally invasive gastrointestinal surgical systems market. Moreover, there is an extensive entry of emerging players developing MIS surgical systems. All these predominant factors have led to a significant rise in sales of minimally invasive gastrointestinal surgical systems across the globe.

Global Minimally Invasive Gastrointestinal Surgical Systems Market (2020-2031)

The global minimally invasive gastrointestinal surgical systems market was valued at $5,021.8 million in 2020 and is anticipated to reach $10,441.0 million by 2031, growing at a CAGR of 6.8% during the forecast period 2021-2031. The increasing complexities in clinical decision-making, rising radiologist workload, and huge R&D investments are the major factors fueling the market growth. In addition to these factors, there are significant challenges and restraints, which are restricting the market growth. These challenges include the shortage of skilled professionals, high cost of minimally invasive GI surgical procedures, and restrictive reimbursement framework. Hence, it is anticipated that these trends will have a significant impact on the minimally invasive gastrointestinal surgical systems market in the during the forecast period, and the market will grow multifold.

Competitive Landscape

The global minimally invasive gastrointestinal surgical systems market consists of numerous large-scale as well as small-scale manufacturers and vendors. Presently, with the increasing adoption of technologies in healthcare, the manufacturers in the market have an ample number of opportunities to expand their offerings and to establish a strong foothold in the market.

From January 2015 to January 2021, the market witnessed approximately 25 regulatory and legal developments, 11 new offerings, 44 partnerships, alliances, and business expansions, four funding activities, and seven mergers and acquisitions activities. Joint ventures, collaborations, and partnerships were among the most frequently followed strategies incorporated by numerous players to establish a strong foothold in the market.

Most of the manufacturers in the market are incorporating collaborations and partnerships with not only other companies but also the university and research institutions as the key strategies to develop novel minimally invasive gastrointestinal surgical systems and attain a strong financial position in the market.

The leading imaging modality providers in the global minimally invasive gastrointestinal surgical systems market include Ambu A/S, B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cook Medical Inc., Intuitive Surgical, Inc., Olympus Corporation, Medtronic plc, Karl Storz SE & Co. KG, Stryker Corporation, Schölly Fiberoptic GmbH, Xenocor Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Richard Wolf GmbH, and TransEnterix, Inc., among others.

Patient Monitoring Devices Market By Type (Hemodynamic Monitoring, Neuromonitoring, Cardiac Monitoring, Fetal & Neonatal Monitoring, Respiratory Monitoring, Multi-Parameter Monitoring, Remote Patient Monitoring, Weigh Monitoring, And Temperature Monitoring Devices); By End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030

The post Global Minimally Invasive Gastrointestinal Surgical Systems Market: 12 Countries Analysis – Analysis and Forecast, 2021-2031 first appeared on CRI Report.